Effects of CPAP on Cognitive Fog in Post-COVID Patients with Obstructive Sleep Apnea

Abstract Study objectives To evaluate whether treatment of comorbid OSA with CPAP improves cognitive fog in patients with post–COVID syndrome. Methods In this prospective, open-label pilot trial, 20 patients with post–COVID syndrome, self-reported cognitive fog, and comorbid OSA completed standardized neurocognitive assessments before and 4±2 weeks after CPAP initiation. The primary outcome was the Montreal Cognitive Assessment (MoCA) and secondary outcome was the PROMIS Cognitive Function T-score. Additional outcomes included measures of executive function (Digit Span Backwards, Trail Making Test B, Stroop Color-Word), processing speed (Digit Symbol Substitution), episodic memory (Benson Complex Delayed Recall), verbal fluency, and vigilance (Psychomotor Vigilance Test). Paired t-tests assessed response to CPAP and linear regression examined dose–response relationships with CPAP use. Results Mean age was 48.7±14.2 years, 55% women, 15% Black, median AHI was 12 [IQR 10–30] events/hour, median time since COVID-19 infection was 29 [IQR 17–44] months, and mean CPAP use was 6.2±2.4 hours/night. Among 17/20 participants who completed follow-up, no significant improvement was observed in MoCA. However, PROMIS Cognitive Function T-score improved by 8.0±2.2 points (43.1±1.7 vs 35.1±1.5; Cohen’s d=-1.0, p<0.01). Greater CPAP use was associated with reduced cognitive symptoms. Significant improvements were observed on Stroop Color-Word, Digit Symbol Substitution, Benson Complex Delayed Recall, and Psychomotor Vigilance Test, whereas Digit Span Backwards, Trail Making Test B, and verbal fluency performance did not improve. Conclusions Our findings suggest that screening and treating comorbid OSA with CPAP in patients with post–COVID syndrome may yield large improvements in cognitive fog symptoms.

Authors

Institutions

Publication Details

Journal
SLEEP Advances
Published
2026-11-14
DOI
https://doi.org/10.1093/sleepadvances/zpag124
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of CPAP on Cognitive Fog in Post-COVID Patients with Obstructive Sleep Apnea

Kristine A. Wilckens, Seema Vaidya, Karla Yoney, Sanjay R. Patel et al.
3 links
SLEEP Advances
Obstructive Sleep Apnea Research
article

Effects of CPAP on Cognitive Fog in Post-COVID Patients with Obstructive Sleep Apnea

Kristine A. Wilckens, Seema Vaidya, Karla Yoney, Sanjay R. Patel, Pinar Garbioglu, Venkatesh Krishnamurthy, Alexis B. Whitehead, Steven Swanger, Lokesh Sharma, Seyed Mehdi Nouraie
article en

Abstract

Abstract Study objectives To evaluate whether treatment of comorbid OSA with CPAP improves cognitive fog in patients with post–COVID syndrome. Methods In this prospective, open-label pilot trial, 20 patients with post–COVID syndrome, self-reported cognitive fog, and comorbid OSA completed standardized neurocognitive assessments before and 4±2 weeks after CPAP initiation. The primary outcome was the Montreal Cognitive Assessment (MoCA) and secondary outcome was the PROMIS Cognitive Function T-score. Additional outcomes included measures of executive function (Digit Span Backwards, Trail Making Test B, Stroop Color-Word), processing speed (Digit Symbol Substitution), episodic memory (Benson Complex Delayed Recall), verbal fluency, and vigilance (Psychomotor Vigilance Test). Paired t-tests assessed response to CPAP and linear regression examined dose–response relationships with CPAP use. Results Mean age was 48.7±14.2 years, 55% women, 15% Black, median AHI was 12 [IQR 10–30] events/hour, median time since COVID-19 infection was 29 [IQR 17–44] months, and mean CPAP use was 6.2±2.4 hours/night. Among 17/20 participants who completed follow-up, no significant improvement was observed in MoCA. However, PROMIS Cognitive Function T-score improved by 8.0±2.2 points (43.1±1.7 vs 35.1±1.5; Cohen’s d=-1.0, p<0.01). Greater CPAP use was associated with reduced cognitive symptoms. Significant improvements were observed on Stroop Color-Word, Digit Symbol Substitution, Benson Complex Delayed Recall, and Psychomotor Vigilance Test, whereas Digit Span Backwards, Trail Making Test B, and verbal fluency performance did not improve. Conclusions Our findings suggest that screening and treating comorbid OSA with CPAP in patients with post–COVID syndrome may yield large improvements in cognitive fog symptoms.

SLEEP Advances
University of Pittsburgh (US)
Good health and well-being
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon